Atlas Trials

AST-VAC2 Vaccine in Patients With Non-small Cell Lung Cancer

Clinical trial NCT03371485 · COMPLETED

Trial details

NCT number
NCT03371485
Sponsor
Cancer Research UK
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Non-small Cell Lung Cancer
Start date
2018-05-29
Primary completion
2022-08-08
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.